Outcomes of Implant Removal and Capsulectomy for Breast Implant Illness in 248 Patients

Jacob Y. Katsnelson, MD; Joseph R. Spaniol, MD; Joshua C. Buinewicz, BA; Frederick V. Ramsey, PhD; Brian R. Buinewicz, MD, FACS


Plast Reconstr Surg Glob Open. 2021;9(9):e3813 

In This Article


Our data suggest that in a subset of patients presenting with BII symptoms, there is an underlying inflammatory response associated with the implant capsule, a response which appears to be more common in silicone versus saline and textured versus smooth implants. This response may be associated with symptoms of BII. More research is necessary to further elucidate the underlying process fueling BII; however, in this study, we have demonstrated that implant removal with total capsulectomy can be safely performed in the BII population with minimal complications and high patient satisfaction.